VANCOUVER, BC / ACCESSWIRE / February 24, 2017 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: AXHLF) (the "Company") announces that it has received C$250,000 secured by a General Security Agreement (GSA). The Company will use the funds for its existing digital healthcare business and for its C&C Cosmeceuticals Corp. (C&C) subsidiary's transaction. The GSA will be canceled upon closing of a three-party transaction between C&C, a CBD plant oil extraction company, and an industrial hemp and cannabis farm.
The Company confirms that all consultants' options have expired this month and that the directors and officers have voluntarily elected to cancel all their options to minimize dilution of the Company's share capital. There are no options outstanding for the Company.
Contact:
EVITRADE Health Systems Corporation
(formerly Auxellence Health Corporation)
Twitter: @evitradehealth or https://twitter.com/evitradehealth
Email: [email protected]
Website: http://www.auxellence.com
CSE Micro-site: http://thecse.com/en/listings/technology/evitrade-health-systems-corp
US OTC Markets: http://www.otcmarkets.com/stock/AXHLF/news
About EVITRADE Health (CSE: EVA, OTCQB: AXHLF)
EVITRADE (formerly Auxellence Health Corp.), was founded in 2013 to provide online services for resolving common health problems. The current markets are weight-loss, high blood pressure, high blood glucose and heart arrhythmia.
Disclaimers - Forward Looking Statements
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators and on the OTC Markets website which is posted on www.sedar.com, http://thecse.com/en/listings/technology/evitrade-health-systems-corp, and http://www.otcmarkets.com/stock/AXHLF/filings. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
SOURCE: EVITRADE Health Systems Corp.